0 Σχόλια
0 Μοιράστηκε
229 Views
0 Προεπισκόπηση
Αναζήτηση
Ανακάλυψε νέους ανθρώπους, δημιούργησε νέες συνδέσεις και κάνε καινούργιους φίλους
-
Παρακαλούμε συνδέσου στην Κοινότητά μας για να δηλώσεις τι σου αρέσει, να σχολιάσεις και να μοιραστείς με τους φίλους σου!
-
SGLT2 Inhibitors Market Gains Momentum with Growing Adoption of Advanced TherapiesSGLT2 Inhibitors Market for Diabetes Treatment Market is being significantly propelled by the well-documented cardiovascular and renal protective benefits of SGLT2 inhibitors beyond glycemic management. Landmark clinical trials such as EMPA-REG OUTCOME, CANVAS, and DECLARE-TIMI 58 have demonstrated statistically significant reductions in major adverse cardiovascular events (MACE),...0 Σχόλια 0 Μοιράστηκε 516 Views 0 Προεπισκόπηση
-
SGLT2 Inhibitors Market: Cardiometabolic Health, Drug Innovation & Emerging OpportunitiesAccording to a new report by Polaris Market Research, the global SGLT2 Inhibitors market was valued at USD 18.32 billion in 2025 and is projected to reach USD 33.51 billion by 2034, expanding at a CAGR of 6.90% over the forecast period. Growth is underpinned by rising cardiorenal treatment adoption, expanding type 2 diabetes prevalence, and accelerating new drug approvals across key...0 Σχόλια 0 Μοιράστηκε 281 Views 0 Προεπισκόπηση
-
Global Diabetes Drugs Market Growing at 12.1% CAGR Through 2032According to a new report from Intel Market Research, the global diabetes drugs market was valued at USD 99,880 million in 2024 and is projected to grow from USD 108,000 million in 2025 to USD 218,800 million by 2032, exhibiting a robust CAGR of 12.1% during the forecast period (2025–2032). This growth is driven by the rising global prevalence of diabetes, increased healthcare...0 Σχόλια 0 Μοιράστηκε 1χλμ. Views 0 Προεπισκόπηση